+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Immunoprotein Diagnostic Testing Market - Global Forecast 2026-2032- Product Image
Immunoprotein Diagnostic Testing Market - Global Forecast 2026-2032- Product Image
Sale

Immunoprotein Diagnostic Testing Market - Global Forecast 2026-2032

  • Report

  • 194 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 5888817
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Immunoprotein Diagnostic Testing Market is projected to reach USD 10.79 Billion in 2026. It is expected to continue growing at a CAGR of 7.13%, reaching USD 16.32 Billion by 2032.

Immunoprotein Diagnostic Testing: Executive Overview

Immunoprotein diagnostic testing analyzes antibodies, antigens, complement proteins, immunoglobulins, and related biomarkers to support diagnosis, monitoring, and risk assessment across infectious, autoimmune, inflammatory, oncologic, and immunodeficiency conditions. Its clinical value depends on analytical accuracy, appropriate specimen handling, validated reference ranges, and integration with patient history and complementary testing. Adoption is shaped by laboratory capacity, reimbursement, regulatory requirements, disease burden, and the shift toward earlier and more personalized diagnosis.

How Immunoprotein Testing Is Reshaping Diagnostic Pathways

Diagnostic pathways are moving from isolated measurements toward integrated panels that combine immunoprotein results with molecular, hematology, imaging, and clinical data. Automation, higher-throughput workflows, multiplex platforms, and standardized quality-control procedures are helping laboratories improve reproducibility and turnaround time. At the same time, decentralized and near-patient testing is expanding access where centralized laboratory infrastructure is limited, although these settings require careful controls for operator training, connectivity, calibration, and result interpretation.

Artificial Intelligence Strengthens Interpretation and Workflow Efficiency

Artificial intelligence can support immunoprotein testing by flagging atypical patterns, prioritizing confirmatory tests, identifying quality anomalies, and linking results with longitudinal clinical records. Machine-learning systems may be particularly useful when several immunoprotein markers must be interpreted together or when results are affected by biological and analytical variation. Effective deployment requires representative validation datasets, transparent performance monitoring, cybersecurity, protection of patient data, and clinician oversight; AI should augment rather than replace laboratory and medical judgment.

Regional Insights Across Global Diagnostic Systems

North America benefits from advanced laboratory networks, specialized testing, and established quality frameworks, while reimbursement and regulatory evidence remain important adoption considerations. Europe emphasizes harmonization, laboratory quality, and cross-border regulatory compliance, with the European Union supporting common standards alongside national differences. Asia-Pacific combines sophisticated systems in several economies with substantial unmet needs in emerging settings, creating demand for scalable and accessible workflows. Latin America is shaped by uneven laboratory coverage, public-sector procurement, and the need to extend reliable testing beyond major urban centers. The Middle East is investing in specialized healthcare capacity and referral infrastructure, while the African market is influenced by variable access, workforce constraints, supply continuity, and the expansion of regional laboratory networks.

Group-Level Priorities: ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN countries face diverse regulatory, infrastructure, and workforce conditions, making interoperability and tiered laboratory models important. BRICS members span large and highly varied health systems, with priorities including domestic capacity, affordable access, quality assurance, and resilient supply chains. The European Union places strong emphasis on harmonized regulation, data governance, and laboratory standardization. G7 systems generally have mature diagnostic infrastructure but continue to address cost efficiency, aging populations, workforce pressures, and equitable access. GCC countries are strengthening specialized healthcare and centralized laboratory capabilities, while NATO members increasingly view diagnostic resilience, emergency preparedness, secure supply chains, and interoperable health information as strategic priorities.

Country-Level Signals Shaping Adoption and Implementation

Australia and Canada combine broad public health responsibilities with geographically dispersed populations, making referral logistics, telehealth connectivity, and laboratory consolidation relevant. The United States has extensive specialized testing capacity, with implementation influenced by reimbursement, laboratory regulation, and evidence requirements. Brazil, Mexico, India, China, and Russia must balance large or diverse populations with regional differences in laboratory access, procurement, and domestic manufacturing. Japan, South Korea, France, Germany, Italy, Spain, and the United Kingdom have strong clinical and laboratory capabilities, while aging populations, workforce availability, health-system integration, and budget discipline shape demand for efficient and clinically actionable testing.

Actions for Leaders: Build Reliable, Interoperable, and Equitable Testing

Industry leaders should prioritize clinically validated assays with clearly defined intended uses, robust analytical performance, and transparent interpretation guidance. Investments in automation and AI should be paired with laboratory information-system interoperability, cybersecurity, human-factor testing, and continuous post-deployment monitoring. Organizations can improve resilience by qualifying multiple supply routes, strengthening quality management, and designing workflows for both centralized and decentralized settings. Partnerships with clinicians, public laboratories, regulators, and patient groups can clarify unmet needs, support appropriate-use education, and improve access without compromising result quality.

Research Methodology for the Executive Summary

This summary uses a structured qualitative assessment of immunoprotein diagnostic testing across clinical applications, technologies, healthcare settings, regulatory environments, and geographic systems. The analysis considers laboratory workflow, assay performance, infrastructure, reimbursement, workforce, data integration, and implementation barriers. Regional, group, and country narratives are comparative and evidence-oriented; they do not constitute market estimates, forecasts, market shares, or financial projections. Conclusions should be tested against current regulatory publications, clinical guidelines, laboratory standards, procurement records, and peer-reviewed evidence before operational decisions are made.

Conclusion: Translating Immunoprotein Data into Better Care

Immunoprotein diagnostic testing remains an important foundation for identifying and managing immune-mediated, infectious, inflammatory, and related disorders. Its future impact will depend less on measurement alone and more on dependable interpretation, integration with other diagnostic information, equitable access, and resilient laboratory operations. Leaders that combine validated technology with strong quality systems, responsible AI governance, interoperable data, and regionally appropriate delivery models will be better positioned to convert immunoprotein results into timely and clinically meaningful decisions.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Immunoprotein Diagnostic Testing Market, by Product Type
7.1. Introduction
7.2. Reagents & Kits
7.2.1. Immunoassay Kits
7.2.2. ELISA Kits
7.2.3. Nephelometry Reagents
7.3. Instruments & Analyzers
7.3.1. Immunoassay Analyzers
7.3.2. Nephelometers
7.3.3. Turbidimeters
7.4. Consumables
7.4.1. Cuvettes
7.4.2. Microplates
7.5. Software & Services
7.5.1. Data Analysis Software
7.5.2. Maintenance Services
7.5.3. Calibration Services
8. Immunoprotein Diagnostic Testing Market, by Sample Type
8.1. Introduction
8.2. Plasma
8.3. Serum
8.4. Urine
8.5. Whole Blood
9. Immunoprotein Diagnostic Testing Market, by Technology
9.1. Introduction
9.2. Enzyme Linked Immunosorbent Assay
9.3. Chemiluminescent Immunoassay
9.4. Fluorescence Immunoassay
9.5. Radioimmunoassay
10. Immunoprotein Diagnostic Testing Market, by Analyte Type
10.1. Introduction
10.2. Immunoglobulins
10.2.1. IgG
10.2.2. IgA
10.2.3. IgM
10.3. Complement Proteins
10.3.1. C3
10.3.2. C4
10.4. Cardiac Markers
10.5. Inflammatory Markers
10.5.1. Ferritin
10.5.2. Procalcitonin
11. Immunoprotein Diagnostic Testing Market, by Application
11.1. Introduction
11.2. Autoimmune Disorders
11.2.1. Multiple Sclerosis
11.2.2. Rheumatoid Arthritis
11.2.3. Sjogren Syndrome
11.2.4. Type 1 Diabetes
11.3. Cardiovascular Diseases
11.4. Infectious Diseases
11.4.1. Covid-19
11.4.2. Hepatitis
11.4.3. Hiv
11.4.4. Influenza
11.5. Oncology
12. Immunoprotein Diagnostic Testing Market, by End User
12.1. Introduction
12.2. Clinic
12.3. Diagnostic Laboratory
12.4. Hospital
12.5. Research Institute
13. Immunoprotein Diagnostic Testing Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Immunoprotein Diagnostic Testing Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Immunoprotein Diagnostic Testing Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Abbott Laboratories
17.2. Agilent Technologies, Inc.
17.3. Becton, Dickinson and Company
17.4. Bio-Rad Laboratories, Inc.
17.5. Bio-Techne Corporation
17.6. Calbiotech, Inc.
17.7. Danaher Corporation
17.8. DiaSorin S.p.A.
17.9. DiaSys Diagnostic Systems GmbH
17.10. Enzo Biochem, Inc.
17.11. Eurofins Scientific
17.12. F. Hoffmann-La Roche Ltd.
17.13. Fujifilm Holdings Corporation
17.14. Grifols, S.A.
17.15. Merck KGaA
17.16. Myriad Genetics, Inc.
17.17. QIAGEN N.V.
17.18. QuidelOrtho Corporation
17.19. Randox Laboratories Ltd.
17.20. Siemens Healthineers AG
17.21. Sysmex Corporation
17.22. Thermo Fisher Scientific Inc.
17.23. Werfen, S.A.
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Immunoprotein Diagnostic Testing Market, Years Considered for the Study
FIGURE 2. Global Immunoprotein Diagnostic Testing Market, Research Design
FIGURE 3. Global Immunoprotein Diagnostic Testing Market, Research Framework
FIGURE 4. Global Immunoprotein Diagnostic Testing Market, Data Triangulation
FIGURE 5. Global Immunoprotein Diagnostic Testing Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Immunoprotein Diagnostic Testing Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Immunoprotein Diagnostic Testing Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Immunoprotein Diagnostic Testing Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 9. Global Immunoprotein Diagnostic Testing Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Immunoprotein Diagnostic Testing Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 11. Global Immunoprotein Diagnostic Testing Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Immunoprotein Diagnostic Testing Market Size, by Analyte Type, 2025 vs 2032 (%)
FIGURE 13. Global Immunoprotein Diagnostic Testing Market Size, by Analyte Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Immunoprotein Diagnostic Testing Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global Immunoprotein Diagnostic Testing Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Immunoprotein Diagnostic Testing Market Size, by End User, 2025 vs 2032 (%)
FIGURE 17. Global Immunoprotein Diagnostic Testing Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Immunoprotein Diagnostic Testing Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Immunoprotein Diagnostic Testing Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Immunoprotein Diagnostic Testing Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Immunoprotein Diagnostic Testing Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Immunoprotein Diagnostic Testing Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Immunoprotein Diagnostic Testing Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Immunoprotein Diagnostic Testing Market Segmentation & Coverage
TABLE 2. Global Immunoprotein Diagnostic Testing Market Size, 2017-2032 (USD Million)
TABLE 3. Global Immunoprotein Diagnostic Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Reagents & Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Reagents & Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Reagents & Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Immunoassay Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Immunoassay Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Immunoassay Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global ELISA Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global ELISA Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global ELISA Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Nephelometry Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Nephelometry Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Nephelometry Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Instruments & Analyzers Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Instruments & Analyzers Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Instruments & Analyzers Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Immunoassay Analyzers Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Immunoassay Analyzers Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Immunoassay Analyzers Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Nephelometers Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Nephelometers Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Nephelometers Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Turbidimeters Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Turbidimeters Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Turbidimeters Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Consumables Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Consumables Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Consumables Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Cuvettes Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Cuvettes Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Cuvettes Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Microplates Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Microplates Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Microplates Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Software & Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Software & Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Software & Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Data Analysis Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Data Analysis Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Data Analysis Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Maintenance Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Maintenance Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Maintenance Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Calibration Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Calibration Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Calibration Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Immunoprotein Diagnostic Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 50. Global Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Plasma Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Serum Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Serum Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Serum Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Urine Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Urine Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Urine Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Whole Blood Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Whole Blood Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Whole Blood Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Immunoprotein Diagnostic Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 63. Global Enzyme Linked Immunosorbent Assay Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Enzyme Linked Immunosorbent Assay Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Enzyme Linked Immunosorbent Assay Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Chemiluminescent Immunoassay Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Chemiluminescent Immunoassay Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Chemiluminescent Immunoassay Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Fluorescence Immunoassay Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Fluorescence Immunoassay Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Fluorescence Immunoassay Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Radioimmunoassay Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Radioimmunoassay Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Radioimmunoassay Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Immunoprotein Diagnostic Testing Market Size, by Analyte Type, 2017-2032 (USD Million)
TABLE 76. Global Immunoglobulins Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Immunoglobulins Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Immunoglobulins Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global IgG Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global IgG Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global IgG Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global IgA Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global IgA Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global IgA Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global IgM Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global IgM Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global IgM Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Complement Proteins Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Complement Proteins Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Complement Proteins Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global C3 Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global C3 Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global C3 Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global C4 Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global C4 Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global C4 Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Cardiac Markers Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Cardiac Markers Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Cardiac Markers Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Inflammatory Markers Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Inflammatory Markers Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Inflammatory Markers Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Ferritin Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Ferritin Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Ferritin Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Procalcitonin Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Procalcitonin Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Procalcitonin Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Immunoprotein Diagnostic Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 110. Global Autoimmune Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Global Autoimmune Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. Global Autoimmune Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 113. Global Multiple Sclerosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global Multiple Sclerosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global Multiple Sclerosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global Rheumatoid Arthritis Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global Rheumatoid Arthritis Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global Rheumatoid Arthritis Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global Sjogren Syndrome Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global Sjogren Syndrome Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global Sjogren Syndrome Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global Type 1 Diabetes Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Global Type 1 Diabetes Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. Global Type 1 Diabetes Market Size, by Country, 2017-2032 (USD Million)
TABLE 125. Global Cardiovascular Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Global Cardiovascular Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. Global Cardiovascular Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 128. Global Infectious Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 129. Global Infectious Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. Global Infectious Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 131. Global Covid-19 Market Size, by Region, 2017-2032 (USD Million)
TABLE 132. Global Covid-19 Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. Global Covid-19 Market Size, by Country, 2017-2032 (USD Million)
TABLE 134. Global Hepatitis Market Size, by Region, 2017-2032 (USD Million)
TABLE 135. Global Hepatitis Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. Global Hepatitis Market Size, by Country, 2017-2032 (USD Million)
TABLE 137. Global Hiv Market Size, by Region, 2017-2032 (USD Million)
TABLE 138. Global Hiv Market Size, by Group, 2017-2032 (USD Million)
TABLE 139. Global Hiv Market Size, by Country, 2017-2032 (USD Million)
TABLE 140. Global Influenza Market Size, by Region, 2017-2032 (USD Million)
TABLE 141. Global Influenza Market Size, by Group, 2017-2032 (USD Million)
TABLE 142. Global Influenza Market Size, by Country, 2017-2032 (USD Million)
TABLE 143. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 144. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 145. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 146. Global Immunoprotein Diagnostic Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 147. Global Clinic Market Size, by Region, 2017-2032 (USD Million)
TABLE 148. Global Clinic Market Size, by Group, 2017-2032 (USD Million)
TABLE 149. Global Clinic Market Size, by Country, 2017-2032 (USD Million)
TABLE 150. Global Diagnostic Laboratory Market Size, by Region, 2017-2032 (USD Million)
TABLE 151. Global Diagnostic Laboratory Market Size, by Group, 2017-2032 (USD Million)
TABLE 152. Global Diagnostic Laboratory Market Size, by Country, 2017-2032 (USD Million)
TABLE 153. Global Hospital Market Size, by Region, 2017-2032 (USD Million)
TABLE 154. Global Hospital Market Size, by Group, 2017-2032 (USD Million)
TABLE 155. Global Hospital Market Size, by Country, 2017-2032 (USD Million)
TABLE 156. Global Research Institute Market Size, by Region, 2017-2032 (USD Million)
TABLE 157. Global Research Institute Market Size, by Group, 2017-2032 (USD Million)
TABLE 158. Global Research Institute Market Size, by Country, 2017-2032 (USD Million)
TABLE 159. Global Immunoprotein Diagnostic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 160. Asia-Pacific Immunoprotein Diagnostic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 161. Asia-Pacific Immunoprotein Diagnostic Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 162. Asia-Pacific Immunoprotein Diagnostic Testing Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 163. Asia-Pacific Immunoprotein Diagnostic Testing Market Size, by Instruments & Analyzers, 2017-2032 (USD Million)
TABLE 164. Asia-Pacific Immunoprotein Diagnostic Testing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 165. Asia-Pacific Immunoprotein Diagnostic Testing Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 166. Asia-Pacific Immunoprotein Diagnostic Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 167. Asia-Pacific Immunoprotein Diagnostic Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 168. Asia-Pacific Immunoprotein Diagnostic Testing Market Size, by Analyte Type, 2017-2032 (USD Million)
TABLE 169. Asia-Pacific Immunoprotein Diagnostic Testing Market Size, by Immunoglobulins, 2017-2032 (USD Million)
TABLE 170. Asia-Pacific Immunoprotein Diagnostic Testing Market Size, by Complement Proteins, 2017-2032 (USD Million)
TABLE 171. Asia-Pacific Immunoprotein Diagnostic Testing Market Size, by Inflammatory Markers, 2017-2032 (USD Million)
TABLE 172. Asia-Pacific Immunoprotein Diagnostic Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 173. Asia-Pacific Immunoprotein Diagnostic Testing Market Size, by Autoimmune Disorders, 2017-2032 (USD Million)
TABLE 174. Asia-Pacific Immunoprotein Diagnostic Testing Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 175. Asia-Pacific Immunoprotein Diagnostic Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 176. North America Immunoprotein Diagnostic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 177. North America Immunoprotein Diagnostic Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 178. North America Immunoprotein Diagnostic Testing Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 179. North America Immunoprotein Diagnostic Testing Market Size, by Instruments & Analyzers, 2017-2032 (USD Million)
TABLE 180. North America Immunoprotein Diagnostic Testing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 181. North America Immunoprotein Diagnostic Testing Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 182. North America Immunoprotein Diagnostic Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 183. North America Immunoprotein Diagnostic Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 184. North America Immunoprotein Diagnostic Testing Market Size, by Analyte Type, 2017-2032 (USD Million)
TABLE 185. North America Immunoprotein Diagnostic Testing Market Size, by Immunoglobulins, 2017-2032 (USD Million)
TABLE 186. North America Immunoprotein Diagnostic Testing Market Size, by Complement Proteins, 2017-2032 (USD Million)
TABLE 187. North America Immunoprotein Diagnostic Testing Market Size, by Inflammatory Markers, 2017-2032 (USD Million)
TABLE 188. North America Immunoprotein Diagnostic Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 189. North America Immunoprotein Diagnostic Testing Market Size, by Autoimmune Disorders, 2017-2032 (USD Million)
TABLE 190. North America Immunoprotein Diagnostic Testing Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 191. North America Immunoprotein Diagnostic Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 192. Latin America Immunoprotein Diagnostic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 193. Latin America Immunoprotein Diagnostic Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 194. Latin America Immunoprotein Diagnostic Testing Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 195. Latin America Immunoprotein Diagnostic Testing Market Size, by Instruments & Analyzers, 2017-2032 (USD Million)
TABLE 196. Latin America Immunoprotein Diagnostic Testing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 197. Latin America Immunoprotein Diagnostic Testing Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 198. Latin America Immunoprotein Diagnostic Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 199. Latin America Immunoprotein Diagnostic Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 200. Latin America Immunoprotein Diagnostic Testing Market Size, by Analyte Type, 2017-2032 (USD Million)
TABLE 201. Latin America Immunoprotein Diagnostic Testing Market Size, by Immunoglobulins, 2017-2032 (USD Million)
TABLE 202. Latin America Immunoprotein Diagnostic Testing Market Size, by Complement Proteins, 2017-2032 (USD Million)
TABLE 203. Latin America Immunoprotein Diagnostic Testing Market Size, by Inflammatory Markers, 2017-2032 (USD Million)
TABLE 204. Latin America Immunoprotein Diagnostic Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 205. Latin America Immunoprotein Diagnostic Testing Market Size, by Autoimmune Disorders, 2017-2032 (USD Million)
TABLE 206. Latin America Immunoprotein Diagnostic Testing Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 207. Latin America Immunoprotein Diagnostic Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 208. Europe Immunoprotein Diagnostic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 209. Europe Immunoprotein Diagnostic Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 210. Europe Immunoprotein Diagnostic Testing Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 211. Europe Immunoprotein Diagnostic Testing Market Size, by Instruments & Analyzers, 2017-2032 (USD Million)
TABLE 212. Europe Immunoprotein Diagnostic Testing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 213. Europe Immunoprotein Diagnostic Testing Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 214. Europe Immunoprotein Diagnostic Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 215. Europe Immunoprotein Diagnostic Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 216. Europe Immunoprotein Diagnostic Testing Market Size, by Analyte Type, 2017-2032 (USD Million)
TABLE 217. Europe Immunoprotein Diagnostic Testing Market Size, by Immunoglobulins, 2017-2032 (USD Million)
TABLE 218. Europe Immunoprotein Diagnostic Testing Market Size, by Complement Proteins, 2017-2032 (USD Million)
TABLE 219. Europe Immunoprotein Diagnostic Testing Market Size, by Inflammatory Markers, 2017-2032 (USD Million)
TABLE 220. Europe Immunoprotein Diagnostic Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 221. Europe Immunoprotein Diagnostic Testing Market Size, by Autoimmune Disorders, 2017-2032 (USD Million)
TABLE 222. Europe Immunoprotein Diagnostic Testing Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 223. Europe Immunoprotein Diagnostic Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 224. Middle East Immunoprotein Diagnostic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 225. Middle East Immunoprotein Diagnostic Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 226. Middle East Immunoprotein Diagnostic Testing Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 227. Middle East Immunoprotein Diagnostic Testing Market Size, by Instruments & Analyzers, 2017-2032 (USD Million)
TABLE 228. Middle East Immunoprotein Diagnostic Testing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 229. Middle East Immunoprotein Diagnostic Testing Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 230. Middle East Immunoprotein Diagnostic Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 231. Middle East Immunoprotein Diagnostic Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 232. Middle East Immunoprotein Diagnostic Testing Market Size, by Analyte Type, 2017-2032 (USD Million)
TABLE 233. Middle East Immunoprotein Diagnostic Testing Market Size, by Immunoglobulins, 2017-2032 (USD Million)
TABLE 234. Middle East Immunoprotein Diagnostic Testing Market Size, by Complement Proteins, 2017-2032 (USD Million)
TABLE 235. Middle East Immunoprotein Diagnostic Testing Market Size, by Inflammatory Markers, 2017-2032 (USD Million)
TABLE 236. Middle East Immunoprotein Diagnostic Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 237. Middle East Immunoprotein Diagnostic Testing Market Size, by Autoimmune Disorders, 2017-2032 (USD Million)
TABLE 238. Middle East Immunoprotein Diagnostic Testing Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 239. Middle East Immunoprotein Diagnostic Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 240. Africa Immunoprotein Diagnostic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 241. Africa Immunoprotein Diagnostic Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 242. Africa Immunoprotein Diagnostic Testing Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 243. Africa Immunoprotein Diagnostic Testing Market Size, by Instruments & Analyzers, 2017-2032 (USD Million)
TABLE 244. Africa Immunoprotein Diagnostic Testing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 245. Africa Immunoprotein Diagnostic Testing Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 246. Africa Immunoprotein Diagnostic Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 247. Africa Immunoprotein Diagnostic Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 248. Africa Immunoprotein Diagnostic Testing Market Size, by Analyte Type, 2017-2032 (USD Million)
TABLE 249. Africa Immunoprotein Diagnostic Testing Market Size, by Immunoglobulins, 2017-2032 (USD Million)
TABLE 250. Africa Immunoprotein Diagnostic Testing Market Size, by Complement Proteins, 2017-2032 (USD Million)
TABLE 251. Africa Immunoprotein Diagnostic Testing Market Size, by Inflammatory Markers, 2017-2032 (USD Million)
TABLE 252. Africa Immunoprotein Diagnostic Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 253. Africa Immunoprotein Diagnostic Testing Market Size, by Autoimmune Disorders, 2017-2032 (USD Million)
TABLE 254. Africa Immunoprotein Diagnostic Testing Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 255. Africa Immunoprotein Diagnostic Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 256. Global Immunoprotein Diagnostic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 257. ASEAN Immunoprotein Diagnostic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 258. ASEAN Immunoprotein Diagnostic Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 259. ASEAN Immunoprotein Diagnostic Testing Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 260. ASEAN Immunoprotein Diagnostic Testing Market Size, by Instruments & Analyzers, 2017-2032 (USD Million)
TABLE 261. ASEAN Immunoprotein Diagnostic Testing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 262. ASEAN Immunoprotein Diagnostic Testing Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 263. ASEAN Immunoprotein Diagnostic Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 264. ASEAN Immunoprotein Diagnostic Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 265. ASEAN Immunoprotein Diagnostic Testing Market Size, by Analyte Type, 2017-2032 (USD Million)
TABLE 266. ASEAN Immunoprotein Diagnostic Testing Market Size, by Immunoglobulins, 2017-2032 (USD Million)
TABLE 267. ASEAN Immunoprotein Diagnostic Testing Market Size, by Complement Proteins, 2017-2032 (USD Million)
TABLE 268. ASEAN Immunoprotein Diagnostic Testing Market Size, by Inflammatory Markers, 2017-2032 (USD Million)
TABLE 269. ASEAN Immunoprotein Diagnostic Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 270. ASEAN Immunoprotein Diagnostic Testing Market Size, by Autoimmune Disorders, 2017-2032 (USD Million)
TABLE 271. ASEAN Immunoprotein Diagnostic Testing Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 272. ASEAN Immunoprotein Diagnostic Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 273. GCC Immunoprotein Diagnostic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 274. GCC Immunoprotein Diagnostic Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 275. GCC Immunoprotein Diagnostic Testing Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 276. GCC Immunoprotein Diagnostic Testing Market Size, by Instruments & Analyzers, 2017-2032 (USD Million)
TABLE 277. GCC Immunoprotein Diagnostic Testing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 278. GCC Immunoprotein Diagnostic Testing Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 279. GCC Immunoprotein Diagnostic Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 280. GCC Immunoprotein Diagnostic Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 281. GCC Immunoprotein Diagnostic Testing Market Size, by Analyte Type, 2017-2032 (USD Million)
TABLE 282. GCC Immunoprotein Diagnostic Testing Market Size, by Immunoglobulins, 2017-2032 (USD Million)
TABLE 283. GCC Immunoprotein Diagnostic Testing Market Size, by Complement Proteins, 2017-2032 (USD Million)
TABLE 284. GCC Immunoprotein Diagnostic Testing Market Size, by Inflammatory Markers, 2017-2032 (USD Million)
TABLE 285. GCC Immunoprotein Diagnostic Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 286. GCC Immunoprotein Diagnostic Testing Market Size, by Autoimmune Disorders, 2017-2032 (USD Million)
TABLE 287. GCC Immunoprotein Diagnostic Testing Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 288. GCC Immunoprotein Diagnostic Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 289. European Union Immunoprotein Diagnostic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 290. European Union Immunoprotein Diagnostic Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 291. European Union Immunoprotein Diagnostic Testing Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 292. European Union Immunoprotein Diagnostic Testing Market Size, by Instruments & Analyzers, 2017-2032 (USD Million)
TABLE 293. European Union Immunoprotein Diagnostic Testing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 294. European Union Immunoprotein Diagnostic Testing Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 295. European Union Immunoprotein Diagnostic Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 296. European Union Immunoprotein Diagnostic Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 297. European Union Immunoprotein Diagnostic Testing Market Size, by Analyte Type, 2017-2032 (USD Million)
TABLE 298. European Union Immunoprotein Diagnostic Testing Market Size, by Immunoglobulins, 2017-2032 (USD Million)
TABLE 299. European Union Immunoprotein Diagnostic Testing Market Size, by Complement Proteins, 2017-2032 (USD Million)
TABLE 300. European Union Immunoprotein Diagnostic Testing Market Size, by Inflammatory Markers, 2017-2032 (USD Million)
TABLE 301. European Union Immunoprotein Diagnostic Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 302. European Union Immunoprotein Diagnostic Testing Market Size, by Autoimmune Disorders, 2017-2032 (USD Million)
TABLE 303. European Union Immunoprotein Diagnostic Testing Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 304. European Union Immunoprotein Diagnostic Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 305. BRICS Immunoprotein Diagnostic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 306. BRICS Immunoprotein Diagnostic Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 307. BRICS Immunoprotein Diagnostic Testing Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 308. BRICS Immunoprotein Diagnostic Testing Market Size, by Instruments & Analyzers, 2017-2032 (USD Million)
TABLE 309. BRICS Immunoprotein Diagnostic Testing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 310. BRICS Immunoprotein Diagnostic Testing Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 311. BRICS Immunoprotein Diagnostic Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 312. BRICS Immunoprotein Diagnostic Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 313. BRICS Immunoprotein Diagnostic Testing Market Size, by Analyte Type, 2017-2032 (USD Million)
TABLE 314. BRICS Immunoprotein Diagnostic Testing Market Size, by Immunoglobulins, 2017-2032 (USD Million)
TABLE 315. BRICS Immunoprotein Diagnostic Testing Market Size, by Complement Proteins, 2017-2032 (USD Million)
TABLE 316. BRICS Immunoprotein Diagnostic Testing Market Size, by Inflammatory Markers, 2017-2032 (USD Million)
TABLE 317. BRICS Immunoprotein Diagnostic Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 318. BRICS Immunoprotein Diagnostic Testing Market Size, by Autoimmune Disorders, 2017-2032 (USD Million)
TABLE 319. BRICS Immunoprotein Diagnostic Testing Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 320. BRICS Immunoprotein Diagnostic Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 321. G7 Immunoprotein Diagnostic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 322. G7 Immunoprotein Diagnostic Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 323. G7 Immunoprotein Diagnostic Testing Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 324. G7 Immunoprotein Diagnostic Testing Market Size, by Instruments & Analyzers, 2017-2032 (USD Million)
TABLE 325. G7 Immunoprotein Diagnostic Testing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 326. G7 Immunoprotein Diagnostic Testing Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 327. G7 Immunoprotein Diagnostic Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 328. G7 Immunoprotein Diagnostic Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 329. G7 Immunoprotein Diagnostic Testing Market Size, by Analyte Type, 2017-2032 (USD Million)
TABLE 330. G7 Immunoprotein Diagnostic Testing Market Size, by Immunoglobulins, 2017-2032 (USD Million)
TABLE 331. G7 Immunoprotein Diagnostic Testing Market Size, by Complement Proteins, 2017-2032 (USD Million)
TABLE 332. G7 Immunoprotein Diagnostic Testing Market Size, by Inflammatory Markers, 2017-2032 (USD Million)
TABLE 333. G7 Immunoprotein Diagnostic Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 334. G7 Immunoprotein Diagnostic Testing Market Size, by Autoimmune Disorders, 2017-2032 (USD Million)
TABLE 335. G7 Immunoprotein Diagnostic Testing Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 336. G7 Immunoprotein Diagnostic Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 337. NATO Immunoprotein Diagnostic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 338. NATO Immunoprotein Diagnostic Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 339. NATO Immunoprotein Diagnostic Testing Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 340. NATO Immunoprotein Diagnostic Testing Market Size, by Instruments & Analyzers, 2017-2032 (USD Million)
TABLE 341. NATO Immunoprotein Diagnostic T

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Calbiotech, Inc.
  • Danaher Corporation
  • DiaSorin S.p.A.
  • DiaSys Diagnostic Systems GmbH
  • Enzo Biochem, Inc.
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ltd.
  • Fujifilm Holdings Corporation
  • Grifols, S.A.
  • Merck KGaA
  • Myriad Genetics, Inc.
  • QIAGEN N.V.
  • QuidelOrtho Corporation
  • Randox Laboratories Ltd.
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Werfen, S.A.

Related Topics

Related Reports

Immunoprotein Market - Global Forecast 2026-2032 - Product Image

Immunoprotein Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Immunoprotein Diagnostic Testing - Global Strategic Business Report - Product Image

Immunoprotein Diagnostic Testing - Global Strategic Business Report

  • Report
  • 227 Pages
  • Global
From
Immunoprotein Diagnostic Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Immunoprotein Diagnostic Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 180 Pages
  • Global
From
Immunoprotein Diagnostic Testing Market Outlook 2026-2034: Market Share, and Growth Analysis by Product Type (Instruments, Kits and Reagents, Other Product Types), Technology, Application - Product Image

Immunoprotein Diagnostic Testing Market Outlook 2026-2034: Market Share, and Growth Analysis by Product Type (Instruments, Kits and Reagents, Other Product Types), Technology, Application

  • Report
  • 160 Pages
  • Global
From
Critical Care Diagnostics - Global Strategic Business Report - Product Image

Critical Care Diagnostics - Global Strategic Business Report

  • Report
  • 352 Pages
  • Global
From

About the Immunoprotein Testing Market

Immunoprotein testing is a type of diagnostic test used to detect the presence of specific proteins in the body. These proteins are produced by the immune system in response to a variety of conditions, including infections, autoimmune diseases, and cancer. Immunoprotein tests are used to diagnose and monitor a wide range of diseases, including HIV, hepatitis, and tuberculosis. They can also be used to detect the presence of antibodies, which can indicate a previous exposure to a particular virus or bacteria. Immunoprotein tests are typically performed in a laboratory setting, using a variety of techniques such as enzyme-linked immunosorbent assays (ELISA) and immunofluorescence assays (IFA). These tests are often used in combination with other diagnostic tests, such as blood tests, to provide a more comprehensive picture of a patient's health. The immunoprotein testing market is a rapidly growing segment of the diagnostics industry. It is driven by the increasing prevalence of infectious diseases, the growing demand for personalized medicine, and the development of new technologies. Some of the major players in the immunoprotein testing market include Abbott Laboratories, Becton Dickinson, Bio-Rad Laboratories, Cepheid, DiaSorin, and Roche Diagnostics. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.